Rescheduling cannabis and psychedelics is recommended by AAPP as means to reduce barriers to rigorous clinical research with the goal to strengthen the evidence base on both benefit and harm.
AAPP Releases Policy Asks Related to Cannabis and Psychedelic Research and Rescheduling